Steven M. Greenberg, MD, PhD, FAHA, Chair; Wendy C. Ziai, MD, MPH, FAHA, Vice Chair;
Charlotte Cordonnier, MD, PhD; Dar Dowlatshahi, MD, PhD, FAHA; Brandon Francis, MD …

The expected growth of stroke burden in Korea in early 2000s led to the initiation of a
government-funded clinical research project with the goal of development and …

Importance The reported associations of cerebral microbleeds with recurrent stroke and
intracerebral hemorrhage have raised concerns regarding antithrombotic treatment in …

Background: The appropriate timing of resuming antithrombotic therapy after intracerebral
hemorrhage (ICH) remains unclear. The aim of this study was to compare the risks of major …

Background and Purpose: We investigated the impact of the presence, burden, and location
of cerebral microbleeds (CMBs) on the risk of major adverse cerebrovascular and …

Background and Purpose: Punctate ischemic lesions noted on diffusion-weighted imaging
(DWI) are associated with poor functional outcomes after intracerebral hemorrhage (ICH) …

Background: Stroke risk assessment is an important means of primary prevention, but the
applicability of existing stroke risk assessment scales in the Chinese population has always …

Background and Purpose: Cerebral microbleeds (CMBs) are represented by small areas of
hemosiderin deposition, detected on brain magnetic resonance imaging (MRI), and found …

Major bleeding is a common threat in patients requiring antiplatelet therapy. Timing and
intensity with regard to resumption of antiplatelet therapy represent a major challenge in …

Cerebral microbleeds (CMBs) in the lobar and deep locations are associated with two
distinct pathologies: cerebral amyloid angiopathy and hypertensive arteriopathy. However …